Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter ended September 2023. Sales rose 200.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.07 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 0.21 | 0.07 | 200 |
OPM % | 66.67 | 28.57 | - |
PBDT | 0.15 | 0.02 | 650 |
PBT | 0.15 | 0.02 | 650 |
NP | 0.15 | 0.02 | 650 |

Why Gold Remains a Safe Haven Amid Global Economic Shifts in 2025
4 mins read . Sep 5, 2025

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •